The PhRMA Foundation is an American biopharmaceutical research funding organization based in Washington, D.C. It is the sister organization to Pharmaceutical Research and Manufacturers of America (PhRMA).
Funding
The PhRMA Foundation is funded by its membership, including:[1]
- AbbVie
- Alkermes
- Amgen
- Astellas Pharma
- AstraZeneca
- Bayer
- Biogen
- BioMarin
- Boehringer Ingelheim
- Bristol-Myers Squibb
- CSL
- Daiichi-Sankyo
- Eisai
- Eli Lilly
- EMD Serono
- Genentech
- Gilead Sciences
- GlaxoSmithKline
- Incyte
- Ipsen Biopharmaceuticals
- Johnson & Johnson
- Lundbeck
- Merck
- Novartis
- Novo Nordisk
- Otsuka Pharmaceutical
- Pfizer
- Pharmaceutical Research and Manufacturers of America (PhRMA)
- Sage Therapeutics
- Sanofi
- Sumitomo Pharma
- Sunovion
- Takeda
- Teva Pharmaceuticals
- UCB
Publications
External links
Plump, A., & Miller, A. M. (2022, June). 2021 Annual Report. PhRMA Foundation. https://web.archive.org/web/20230219205032/https://www.phrmafoundation.org/wp-content/uploads/2022/06/PhRMAFoundation_2021AnnualReport.pdf ↩︎
